Revising the Definition of Extensively Drug-Resistant Tuberculosis . Revising the Definition of Extensively Drug-Resistant Tuberculosis Lancet Respir Med. 2018 Dec6(12):893-895. doi: 10.1016/S2213-2600(18)30428-4. Epub 2018 Nov 9. Authors Christoph Lange 1 …
Revising the definition of extensively drug-resistant tuberculosis WHO estimated that in 2017, 460 000 people developed multidrug-resistant (MDR) tuberculosis, defined by bacillary resistance to rifampicin and isoniazid, the two most effective first-line anti-TB drugs.1 Approximately 8·5% of MDR tuberculosis isolates had additional drug, Revising the definition of extensively drug-resistant tuberculosis WHO estimated that in 2017, 460?000 people developed multidrug-resistant (MDR) tuberculosis, defined by bacillary resistance to rifampicin and isoniazid, the two most effective first-line anti-TB drugs. 1, Departmental news. Geneva. Reading time: 2 min (522 words) The definition of extensively drug-resistant tuberculosis (XDR-TB) has been revised by the World Health Organization (WHO)’s Global TB Programme, who have also defined pre-XDR-TB for the first time, highlighting the seriousness of these forms of TB.
2/2/2021 · Reviewed by Emily Henderson, B.Sc. Feb 1 2021 The definition of extensively drug-resistant tuberculosis (XDR-TB) has been revised by the World Health Organization (WHO)’s Global TB Programme, who…
2/2/2021 · written by Aruna February 2, 2021 The definition of extensively drug-resistant tuberculosis (XDR-TB) has been revised by the World Health Organization (WHO)’s Global TB Programme, who have also defined pre-XDR-TB for the first time, highlighting the seriousness of these forms of TB.
1/27/2021 · WHO announces updated definitions of extensively drug-resistant tuberculosis The definition of extensively drug-resistant tuberculosis (XDR-TB) has been revised by the World Health Organization (WHO)’s Global TB Programme, who have also defined pre-XDR-TB for the first time, highlighting the seriousness of these forms of TB.
Extensively drug-resistant TB (XDR TB) is a rare type of multidrug-resistant tuberculosis (MDR TB) that is resistant to isoniazid and rifampin, plus any fluoroquinolone and at least one of three injectable second-line drugs (i.e.
amikacin, kanamycin, or capreomycin).
